Allan L. Goldstein
Founder en REGENERX BIOPHARMACEUTICALS, INC. .
Fortuna: 16 $ al 31/03/2024
Perfil
Allan L.
Goldstein is the founder of RegeneRx Biopharmaceuticals, Inc. (founded in 1982) where he holds the title of Chairman & Chief Scientific Officer.
He is currently working at George Washington University School of Medicine & Health as a Professor since 1978.
Dr. Goldstein has held former positions as a Trustee at Albert B.
Sabin Vaccine Institute, Inc. (2000-2012), a Principal at The University of Texas at Austin (1972-1978), a Trustee at The Richard B.
& Lynne V.
Cheney Cardiovascular Institute (2006-2012), and a Principal at Albert Einstein College of Medicine, Inc. (1964-1972).
Dr. Goldstein's education includes a graduate and doctorate degree from Rutgers State University of New Jersey and an undergraduate degree from Wagner College (New York) obtained in 1959.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/06/2023 | 16 015 ( 1.07% ) | 16 $ | 31/03/2024 |
Cargos activos de Allan L. Goldstein
| Empresas | Cargo | Inicio |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Founder | 13/05/1982 |
| George Washington University School of Medicine & Health | Corporate Officer/Principal | 01/01/1978 |
Antiguos cargos conocidos de Allan L. Goldstein.
| Empresas | Cargo | Fin |
|---|---|---|
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Director/Board Member | 01/01/2012 |
| The Richard B. & Lynne V. Cheney Cardiovascular Institute | Director/Board Member | 01/01/2012 |
| The University of Texas at Austin | Corporate Officer/Principal | 01/01/1978 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 01/01/1972 |
Formación de Allan L. Goldstein.
| Rutgers State University of New Jersey | Doctorate Degree |
| Wagner College (New York) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
| The Richard B. & Lynne V. Cheney Cardiovascular Institute |
- Bolsa de valores
- Insiders
- Allan L. Goldstein
